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S U P P O R T I N G I N F O R M A T I O N
Additional supporting information may be found online in the Supporting Information section at the end of the article. The different natural and recombinant nsLTPs were purified and characterized ( Figure S1 ). rMal d 3, rCor a 8, and nHel a 3 bound the ANS probe to varying extent ( Figure 1A - pronounced reduction of ANS fluorescence, equal to 59%, 23%, and 46% at 50 μmol/L for rMal d 3, rCor a 8, and nHel a 3, respectively.
Eighteen patients' sera containing specific IgE to Pru p 3 and/or
Cor a 8 (Table S1) were tested by direct IgE-ELISA applying rMal d 3, rCor a 8, and nHel a 3 ( Figure S2 ). We used selected sera (n = 6 for rMal d 3 and rCor a 8 each) to test if the IgE binding to the proteins is influenced by the interaction with OLE and STE, chosen as representatives of unsaturated and saturated fatty acid, respectively.
Due to its very low IgE reactivity, nHel a 3 was excluded from this analysis. Preincubation of rMal d 3 with OLE significantly increased IgE-binding (P < 0.05), whereas STE did not affect rMal d 3 IgE-binding properties ( Figure 1E ). Regarding rCor a 8, both fatty acids induced an increase in IgE-binding, but it was statistically significant only for OLE (P < 0.01; Figure 1F ).
We performed computational calculations, detecting some differ- Recently, the direct immunomodulatory effect of food-derived lipids has gained increasing interest. Tordesillas et al showed the adjuvant activity of the natural ligand of Pru p 3 in the allergen sensitization. 9 Summarizing the recent findings, including our data, it still remains to be fully elucidated whether lipids alone or in complexes can activate key players of both, the innate and adaptive immune system within an allergic response.
In FAQLQs were developed to measure the impact of food allergy on HRQL irrespective of the causative food allergen. [1] [2] [3] [4] [5] [6] The FAQLQs were shown to be valid and responsive instruments. [1] [2] [3] [4] [5] [6] At present, it is unknown whether all items contained in these instruments are relevant for peanut-allergic patients and whether intervention studies on peanut allergy would be better served by the existing In order to ascertain whether HRQL items of the FAQLQ-CF, FAQLQ-TF and FAQLQ-AF were suitable to peanut-allergic patients, some retrospective analysis was performed using databases generated during the development and validation of the FAQLQs.
Firstly, all patients with a physician-diagnosed peanut allergy were selected from the development database to identify FAQLQ items that were reported most frequently and had the highest impact scores (ie, overall importance) for peanut-allergic patients (ranging from 1.0 "not" to 5.0 "extremely"). FAIM is an instrument that measures the patients perceived disease severity and has previously been used successfully in validating the FAQLQs. 6 Moderate correlation was to be expected (0.40-0.60). [1] [2] [3] [4] Thirdly, the longitudinal validity 4 of the FAQLQs was determined in a peanut-allergic subgroup. Correlations were calculated between the change in total FAQLQ and the change in total FAIM score of patients who underwent a double-blind placebo-controlled food challenge (DBPCFC) with peanut (longitudinal validity). HRQL was measured 1 month before (baseline) and 6 months after (follow-up) a DBPCFC.
Data were analysed with SPSS software for Windows. Table 1 shows the participant characteristics.
Overall importance analysis showed that all items exceeded the previously used cut-off level of >1.37 in the peanut-allergic subgroup.
1-3 Figure 1 shows that peanut-allergic patients reported a higher overall impact than non-peanut-allergic patients (P < 0.05). Thus, all items may be considered to be important. The Pearson correlation coefficient between the overall importance of peanut-allergic patients and nonpeanut-allergic patients was 0.70, P < 0.001 (FAQLQ-AF), 0.71, P < 0.001 (FAQLQ-TF) and 0.80, P < 0.001 (FAQLQ-CF).
Cross-sectional validity analysis showed that the total FAQLQ score correlated significantly with the total FAIM score in the LETTERS TO THE EDITOR
